GLP-1 receptor agonists have changed the conversation around weight management more dramatically than any class of medication in decades. Tirzepatide and semaglutide, the active compounds behind Mounjaro, Zepbound, Ozempic, and Wegovy, produce weight loss outcomes once achievable only through bariatric surgery. Clinical trials have shown total body weight reductions of 15 to 22 percent, and for millions of people living with obesity or metabolic disease, that is genuinely life-changing. With...

You are eating carefully. You are moving your body. You have done everything you were told to do, and yet the scale has not shifted in weeks. Maybe months. If this sounds familiar, you are not alone, and more importantly, you are probably not doing anything wrong. "Why am I not losing weight?" is one of the most searched health questions globally, and the honest answer is that for many people the barrier is not behavioural. It is biological. Weight regulation is not a simple equation of...

Sometime in your early forties, something shifts. The muscle you built in your twenties and thirties becomes harder to maintain. Recovery takes longer. The composition of your body changes, even when your weight stays the same. You are not imagining it. This is sarcopenia: the age-related, progressive loss of skeletal muscle mass and function that begins silently in your thirties and accelerates with each decade thereafter. For men and women over 40, building strength is no longer just about...